- Global Pharma News & Resources

Press Releases - 2021-03-29

Date Title Company
29-Mar-2021 Novel Phenomics NASH In Vitro Assay Presented by InSphero AG and PharmaNest Inc at 2021 Society of Toxicology Meeting Newswire
29-Mar-2021 gaitQ Awarded Grant by the UK’s National Institute for Health Research for the continued development of its system gaitQ
29-Mar-2021 EMA issues advice on the use of Celltrion’s anti-COVID-19 monoclonal antibody treatment regdanvimab (CT-P59) for COVID-19 patients in the European Union Celltrion Group
29-Mar-2021 Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations Autolus Therapeutics plc
29-Mar-2021 The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health Prioritization from the UK government UNION therapeutics A/S
29-Mar-2021 HUTCHMED Initiates International Phase I Trials of IDH1/2 Dual Inhibitor in Patients with Advanced Solid Tumors or Hematological Malignancies HUTCHMED
29-Mar-2021 OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer OKYO Pharma Limited
29-Mar-2021 Instant Covid Tests London to launch first test centre using 20-second Virolens technology Instant Covid Tests London (ICTL)
29-Mar-2021 Syncona cornerstones $148 million Series C Financing in Gyroscope Syncona Ltd
29-Mar-2021 Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation Vertex Pharmaceuticals Incorporated
29-Mar-2021 Gadopiclenol: positive results for Phase III clinical trials Guerbet
29-Mar-2021 Avifavir obtains its first registration in Asia Russian Direct Investment Fund
29-Mar-2021 PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKey PrecisionLife
29-Mar-2021 HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors Hutchison China MediTech Limited
29-Mar-2021 Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery University of Birmingham
29-Mar-2021 LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology Nordic Capital
29-Mar-2021 Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials Amzell BV
29-Mar-2021 Qlucore announces major new release (3.7) with ChIP-seq and Biomarker support Qlucore
29-Mar-2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Augustine Therapeutics
29-Mar-2021 Sputnik V approved in Vietnam The Russian Direct Investment Fund